Patient Reported Outcome Data from Acromegaly Patients Treated with Injectable Somatostatin Analogues in Routine Clinical Practice: Preliminary Results

The poster below summarizes findings reported by the patient responders, who despite their stable treatment dosage, reported significant burden of disease including inadequate symptom control and treatment dissatisfaction.

Geer EB, Sisco J, Adelman DT, et al. Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice. BMC Endocrine Disorders. 2020;20:117. doi:10.1186/s12902-020-00595-4